To address the threat of STIs, NIAID officials recommend a new focus on research for diagnostics, treatments, and vaccines.

Monday, September 9, 2019 NIAID Officials Call for Innovative Research on Sexually Transmitted Infections NIAID experts call for a renewed focus on sexually transmitted infections. Rates of gonorrhea, syphilis, and chlamydia are all on the rise, and some STIs are developing resistance to common treatments. In a new perspective piece in The Journal of Infectious Diseases, NIAID officials write that biomedical research establishments must work together to develop better diagnostics, treatments and vaccine candidates for STIs. National Institute of Allergy and Infectious Diseases  |  National Institutes of Health Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID). This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107